Latest News

The newly FDA-cleared PACS Viewer from CliniComp reportedly allows direct review and analysis of imaging within a patient’s chart.

In a recent interview, Nina Kottler, MD, offered her perspective on findings from a recent report on AI in health care, AI integration challenges and what the future holds with AI in radiology.

In comparison to everolimus, the peptide receptor radionuclide therapy (177Lu)Lu-edotreotide provided over a nine month longer median progression-free survival for patients with gastroenteropancreatic neuroendocrine tumours (GEP NETs), according to new phase 3 research.

In an amusing take on the subject, this author suggests that having a colleague with dedicated expertise in curtailing unnecessary imaging requests could have an impact in reducing burgeoning worklists.

Catch up on the top radiology content of the past week.

For patients with known or suspected neuroendocrine tumors, the radiopharmaceutical 64Cu-SARTATE offered over 50 percent higher average detection of liver foci than 68Ga-DOTATATE at four hours and 20 hours post-injection, according to research presented at the recent SNMMI conference.

In a recent interview, Amy Patel, MD, discussed recent research on breast cancer screening, pertinent obstacles and keys to facilitating improved adherence with mammography screening.

While acknowledging key limitations, the authors of a new literature review noted that contrast-enhanced mammography offers a viable alternative to conventional imaging and breast MRI for preoperative tumor evaluation and may have a significant impact on surgical management.

Emerging research demonstrates that those with total plaque volume > 750 mm3 have an 18.6 percent risk of MACE at four years in comparison to a 1.4 percent MACE risk for those with no plaque.

In comparison to the 2009 International Federation of Gynecology and Obstetrics (FIGO) staging system for endometrial cancer, researchers found that the updated 2023 FIGO system had over a 17 percent decrease for substage agreement between pelvic MRI and pathology findings.

The Mammomat B.brilliant’s ClearCEM image reconstruction technique reportedly utilizes advanced algorithms to facilitate improved noise reduction and lesion enhancement.

Catch up on the most-well viewed radiology content in June 2026.

In recent interviews with Diagnostic Imaging, Jeremie Calais, MD, PhD, Michael Hofman, MBBS, FRACP, Heather Jacene, MD, Phillip Kuo, MD, and more shared their thoughts about the potential impact of theranostics and what excites them about the future of nuclear medicine.